{"id":"oseltamivir-and-chinese-medicinal-herbs","safety":{"commonSideEffects":[{"rate":"10","effect":"Nausea"},{"rate":"8","effect":"Vomiting"},{"rate":"5","effect":"Abdominal pain"},{"rate":"2","effect":"Headache"},{"rate":null,"effect":"Neuropsychiatric events (rare)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Oseltamivir is a neuraminidase inhibitor that blocks the sialic acid receptor on host cells, preventing the release of newly formed influenza virions. The addition of Chinese medicinal herbs (specific composition not standardized in this combination) is intended to enhance immune response and reduce inflammatory symptoms associated with influenza infection, though the exact active components and mechanisms of the herbal component are not well-characterized in conventional pharmacology.","oneSentence":"Oseltamivir inhibits viral neuraminidase to prevent influenza virus release, while Chinese medicinal herbs provide adjunctive immunomodulatory and anti-inflammatory support.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:59:10.335Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Influenza A and B infection treatment and prophylaxis"}]},"trialDetails":[{"nctId":"NCT00935194","phase":"PHASE4","title":"Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1) : Multi-centre, Prospective, Randomized Controlled Study","status":"COMPLETED","sponsor":"Capital Medical University","startDate":"2009-07","conditions":"Influenza","enrollment":102},{"nctId":"NCT00936013","phase":"PHASE4","title":"Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1)Pneumonia: Multi-centre, Prospective, Randomized Controlled Study","status":"UNKNOWN","sponsor":"Capital Medical University","startDate":"2009-08","conditions":"Influenza","enrollment":400}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"oseltamivir and chinese medicinal herbs","genericName":"oseltamivir and chinese medicinal herbs","companyName":"Capital Medical University","companyId":"capital-medical-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Oseltamivir inhibits viral neuraminidase to prevent influenza virus release, while Chinese medicinal herbs provide adjunctive immunomodulatory and anti-inflammatory support. Used for Influenza A and B infection treatment and prophylaxis.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}